Zur Hauptnavigation wechseln
Zur Suche wechseln
Zum Hauptinhalt wechseln
sortieren
Pharmacology, Toxicology and Pharmaceutical Science
Peritoneal Dialysis Fluid
100%
Peritoneal Dialysis Fluid
47%
Meropenem
47%
Pharmacokinetics
35%
Escherichia coli
27%
Dialysis Fluid
24%
Fosfomycin
23%
Linezolid
23%
Ciprofloxacin
23%
Cefepime
23%
Peritonitis
22%
Minimum Inhibitory Concentration
22%
Antimicrobial Agent
16%
Icodextrin
16%
Pseudomonas aeruginosa
13%
Kidney Disease
13%
Cohort Study
12%
Infection
12%
Antibiotics
11%
Glutamine
11%
Lipegfilgrastim
11%
Staphylococcus Epidermidis
11%
Daptomycin
11%
Recombinant Erythropoietin
11%
Pure Red Cell Anemia
11%
Aztreonam
11%
Ertapenem
11%
Tobramycin
11%
Rituximab
11%
Ampicillin
11%
Enterococcus faecalis
11%
Staphylococcus Aureus
11%
Randomized Controlled Trial
11%
Biological Marker
11%
Chronic Kidney Failure
11%
Adverse Event
11%
High Performance Liquid Chromatography
10%
Chemotherapy
9%
Neutropenia
5%
Brain Ischemia
5%
Infectious Agent
5%
Medicine and Dentistry
Randomized Controlled Trial
35%
Nephrology
25%
Peritoneal Dialysis
25%
Pre-Eclampsia
23%
Gestational Diabetes
23%
Diseases
14%
Chronic Kidney Disease
13%
Renal Replacement Therapy
13%
Maturity Onset Diabetes of the Young
13%
Nephropathy
11%
Breast Radiotherapy
11%
Outpatient
11%
Hormone Therapy
11%
Quadrantectomy
11%
Patient with Type 2 Diabetes
11%
Glycemic Control
11%
Breast Cancer
11%
Peer Group
11%
Cardiovascular Risk
11%
Hypervolemia
11%
Diabetes
11%
Colorectal Carcinoma
11%
Glutamine
11%
Aortic Stenosis
11%
Percutaneous Aortic Valve Replacement
11%
Risk Perception
11%
Health Care
11%
COVID-19
11%
Internal Medicine
11%
End Stage Renal Disease
11%
Supplementation
11%
Kidney Disorder
11%
Biological Marker
11%
Peritoneal Dialysis Fluid
11%
Disease
11%
Cardiovascular Disease
11%
Health Care Personnel
9%
Prevalence
9%
Nephrologist
9%
Health Care Cost
8%
Kidney Graft
7%
Decision Making
5%
Diabetes Mellitus
5%
Puerperium
5%
Non Communicable Disease
5%
Personal Experience
5%
Kidney Function
5%
Congestive Heart Failure
5%
Awareness
5%
Immunology and Microbiology
Peritoneal Dialysis
95%
Solution and Solubility
41%
In Vitro
35%
Escherichia coli
29%
Peritonitis
28%
Minimum Inhibitory Concentration
18%
Antimicrobial Agent
18%
Antimicrobial Activity
18%
Infection
17%
Pseudomonas aeruginosa
15%
Lipegfilgrastim
11%
Staphylococcus Epidermidis
11%
Rituximab
11%
Autoimmunity
11%
Glutamine
11%
Staphylococcus Aureus
11%
Enterococcus faecalis
11%
Pharmacokinetics
11%
Disk Diffusion
9%
High Performance Liquid Chromatography
9%
Drug Adsorption
9%
Room Temperature
8%
Body Temperature
8%
High Performance Liquid Chromatography-Mass Spectrometry
5%
Blood Plasma
5%
Infectious Agent
5%
Susceptibility
5%
Drug Concentration
5%
